PENGARUH PEMBERIAN ASAM KLOROGENAT TERHADAP EKSPRESI mRNA TLR-4, mRNA MCP-1, JUMLAH MAKROFAG M1 DAN M2 PADA GINJAL MENCIT SWISS WEBSTER DENGAN MODEL UNILATERAL URETERAL OBSTRUCTION (UUO)
Abstract
Penyakit ginjal kronis (CKD) adalah masalah kesehatan global dengan prognosis buruk yang mengarah ke fibrosis ginjal. Obstruksi ureter unilateral (UUO) adalah metode yang representatif untuk memodelkan fibrosis ginjal. Penelitian ini merupakan penelitian kuasi eksperimen dengan desain kelompok post-test dengan 25 ekor mencit Swiss Webster jantan dewasa yang dibagi menjadi lima kelompok, yaitu SO, U7, U14, UC7, UC14. Ekspresi mRNA TLR-4 diperiksa dan mRNA MCP-1 diperiksa oleh RT-PCR. Jumlah makrofag M1 dan M2 dengan pewarnaan IHC. Data diproses menggunakan SPSS. Pada kelompok yang diinduksi UUO dan yang diinjeksi Aquadest, ekspresi mRNA TLR-4, mRNA MCP-1 dan jumlah makrofag M1 dan M2 lebih tinggi daripada kelompok kontrol (p<0,005), sedangkan kelompok yang diinduksi UUO dan diinduksi kelompok asam klorogenik menunjukkan mRNA TLR-4, mRNA MCP-1, jumlah makrofag M1 yang lebih rendah dan jumlah makrofag M2 yang lebih tinggi dibandingkan dengan kelompok UUO yang diinjeksi dengan Aquadest (p<0,005). Pemberian asam klorogenat dapat mencegah fibrosis ginjal dengan cara menurunkan ekspresi mRNA TLR-4, mRNA MCP-1, jumlah makrofag M1 dan meningkatkan jumlah mRNA M2.
Downloads
References
Badan Penelitian dan Pengembangan Kesehatan Kementerian Kesehatan RI. Riset Kesehatan Dasar. Jakarta: Kementerian Kesehatan RI. 2013.
Ucero, A.C., Benito-Martin, A., Izquierdo, M.C., Sanchez-Nino, M.D., Sanz, A., Ramos, A.M., et al. Unilateral Ureteral Obstruction: Beyond Obstruction. Int Urol Nephrol. 2014; 46(4): 765–776.
Wang, W., Zhou, P. H., Xu, C. G., Zhou, X. J., Hu, W., Zhang, J. Baicalein attenuates renal fibrosis by inhibiting inflammation via down-regulating NF-κB and MAPK signal pathways. J Mol Histol. 2015; 46(3): 283–290.
Efstratiadis, G., Divani, M., Katsioulis, E., Vergoulas, G. Renal Fibrosis. Hippokratia. 2009; 13(4): 224-228.
Eddy, A. Overview of the cellular and molecular basis of kidney fibrosis. Kidney Int Suppl. 2014; 4(1): 2–8.
Yiu, W. H., Lin, M., Tang, S. C. W. Toll-like receptor activation: from renal inflammation to fibrosis. Kidney Int suppl. 2014; 4(1): 20–25.
Pulskens, W. P., Rampanelli, E., Teske, G. J., Butter, L. M., Claessen, N., Luirink, I. K., Van der Poll, T., et al. TLR4 promotes fibrosis but attenuates tubular damage in progressive renal injury. J Am Soc Nephrol. 2010; 21(8): 1299-1308.
Skuginna, V., Lech, M., Allam, R., Ryu, M., Clauss, S., Susanti, H. E., et al. Toll-like receptor signaling and SIGIRR in renal fibrosis upon unilateral ureteral obstruction. PloS One. 2014; 6(4): 19204.
Adhyatmika, A., Putri, K. S. S., Beljaars, L., Melgert, B. N. The elusive antifibrotic macrophage. Front Med. 2015; 2: 81.
Cao, Q., Wang, Y., Harris, D. C. H. Macrophage heterogeneity, phenotypes, and roles in renal fibrosis. Kidney Int Suppl. 2014; 4(1): 16-19.
Sato, Y., Itagaki, S., Kurokawa, T., Ogura, J., Kobayashi, M., Hirano, T., et al. In Vitro and in Vivo Antioxidant Properties of Chlorogenic Acid and Caffeic Acid. Int J Pharm. 2011; 403(1-2): 136-138.
Domitrović, R., Cvijanović, O., Šušnić, V., Katalinić, N. Renoprotective mechanisms of chlorogenic acid in cisplatin-induced kidney injury. Toxicology. 2014; 324: 98–107.
Pan, B., Liu, G., Jiang, Z., Zheng, D. Regulation of renal fibrosis by macrophage polarization. Cell Physiol Biochem. 2015; 35(3): 1062-1069.
Gueteras, R., Flaquer, M., Cruzado, J. M. Macrophage in chronic kidney disease. Clin Kidney J. 2016; 4:18.
Kim, M. J., Turner, C. M., Hewitt, R., Smith, J., Bhangal, G., Pusey, C., et al. Exaggerated renal fibrosis in P2X4 receptor-deficient mice following unilateral ureteric obstruction. Nephrol Dial Transplant. 2014; 29(7): 1350-1361.
O’Hayre, M., Salanga, C. L., Handel, T. M., Allen, S. J. Chemokines and cancer: migration, intracellular signalling and intercellular communication in the microenvironment. Biochem J. 2008; 409(3): 635–649.
Shen, B., Liu, X., Fan, Y., Qiu, J. Macrophage regulate renal fibrosis through modulating TGFβ superfamily signaling. Inflammation. 2014; 37: 2076-2084.
Sica, A., Mantovani, A. Macrophage plasticity and polarization: in vivo veritas. J Clin Invest. 2012; 122(3): 787-795.
Ma, Y., Gao, M., Liu, D. Chlorogenic acid improves high fat diet-induced hepatic steatosis and insulin resistance in mice. Pharm Res. 2015; 32(4): 1200-1209.
Ohkawara, T., Takeda, H., Nishihira, J. Protective effect og chlorogenic acid on the inflammatory damage of pancreas and lung in mice with L-arginine-induced pancreatitis. Life Sci. 2017; 91-96.
Naveed, M., Hejazi, V., Abbas, M., kamboh A. A., Khan, G. J., Shumzad, M., et al. Chlorogenic acid (CGA): A pharmacological review and call for further research. Biomed pharmacother. 2018; 97: 67-74.
Shi, H., Dong, L., Jiang, J., Zhao, J., Zhao, G., Dang, X., et al. Chlorogenic acid reduces liver inflammation and fibrosis through inhibition of toll-like receptor 4 signaling pathway. Toxicology. 2013; 303: 107-114.
de Borst, M. H., Prakash, J., Sandovici, M., Klok, P., Hamming, I., Kok, R. J., et al. c-Jun NH2-terminal kinase is crucially involved in renal tubulo-interstitial inflammation. J Pharmacol Exp Ther. 2009; 331(3): 896-905.
Yun, N., Kang, J. W., Lee, S. M. Protective effects of chlorogenic acid against ischemia/reperfusion injury in rat liver; molecular evidence of its antioxidant and anti-inflammatory properties. J Nutr Biocherm. 2012; 23(10): 1249-1255.
Copyright (c) 2023 Medika Alkhairaat : Jurnal Penelitian Kedokteran dan Kesehatan

This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with Medika Alkhairaat : Jurnal Penelitian Kedokteran dan Kesehatan agree to the following terms:
1. Authors retain copyright and grant Journal Medika Alkhairaat right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial License (http://creativecommons.org/licenses/by-nc/4.0/) that allows others to remix, adapt, build upon the work non-commercially with an acknowledgement of the work’s authorship and initial publication in Journal Medika Alkhairaat.
2. Authors are permitted to copy and redistribute the journal’s published version of the work non-commercially (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in Journal Medika Alkhairaat.